Skip to main content

View Digital Edition
Original Research
Tolerability of Carboplatin When Using Rounded Serum Creatinine Values
Daniel J. Bestul, PharmD, BCOP, Amy L. Mazloom, PharmD
Read More
FDA Updates, PARP Inhibitors
A Review of PARP Inhibitors in Clinical Development
Sarah Hopps, PharmD, Carla D. Kurkjian, MD, Shubham Pant, MD
Read More
From the Literature, From the Literature
Bevacizumab Delays Progression in Women with Advanced Ovarian Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature, From the Literature
Combination Therapy with Pertuzumab Offers New Option in Metastatic Breast Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature, From the Literature
Chemotherapy-Induced Changes in Brain Structure Correlate with Cognitive Dysfunction
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature, From the Literature
BRAF Inhibitor Therapy Linked to Squamous-Cell Carcinoma in Patients with RAS Mutations
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature, From the Literature
Adding Bevacizumab to Neoadjuvant Chemotherapy Improves Complete Response Rates in Patients with Breast Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More

Results 1 - 7 of 7